HOME >> BIOLOGY >> NEWS
Molecule that destroys bone also protects it, new research shows

BUFFALO, N.Y. -- An immune system component that is a primary cause of bone destruction and inflammation in autoimmune diseases such as rheumatoid arthritis actually protects bone in the oral cavity from infectious pathogens that play a major role in periodontal disease in humans, research at the University at Buffalo has shown.

The component, IL-17, was recognized only in the past 18 months to be a primary cause of bone destruction and inflammation in autoimmune diseases. Therapies that target IL-17 or its cellular receptor currently are being developed.

However, a UB molecular biologist has discovered that, in contrast to its action in rheumatoid arthritis(RA), IL-17 actually protects bone in the oral cavity from infectious pathogens such as Porphyromonas gingivalis, a bacterium that plays a major role in most periodontal disease in humans.

The research findings appear in the current (May) issue of the journal Blood.

Sarah L. Gaffen, Ph.D., associate professor of oral biology in the UB School of Dental Medicine and associate professor of microbiology and immunology in the UB School of Medicine and Biomedical Sciences, is senior author. Jeffrey J. Yu, a medical student and doctoral candidate who is a researcher working in Gaffens lab, is first author.

Gaffen and colleagues conducted the research in mice bred to have no receptors for IL-17. Other researchers had shown previously, using rats and mice as animal models, that blocking the receptor for IL-17 could be an effective therapy for RA and possibly for other autoimmune diseases such as multiple sclerosis, colitis, psoriasis and lupus.

The effects of an IL-17 deficiency in periodontal disease, however, were unknown, so Gaffens lab set out to investigate.

"I predicted these mice without the IL-17 receptor were going to be protected from periodontal bone loss, just like theyre protected from arthritic bone loss," Gaffen said. "In fact, we got the opposite
'"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
8-May-2007


Page: 1 2 3

Related biology news :

1. Molecule blocks gene, sheds light on liver cancer
2. Howard C. Berg honored with Outstanding Investigator in Single Molecule Biology Award
3. Molecule discovered to be key to pain sensitivity
4. Molecules in blood foretell development of preeclampsia
5. Molecule by molecule, new assay shows real-time gene activity
6. Molecule does more than slice and dice RNA
7. Molecule links Down syndrome to Alzheimers
8. Molecule crucial for processing non-coding RNA identified
9. Molecule on immune cells linked to sexual transmission of HIV
10. Molecule that usually protects infection-fighting cells may cause plaque deposits inside arteries
11. Molecule that helps DNA replicate may make good target for cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2020)... ... 07, 2020 , ... dicentra , a leading clinical ... and dietary supplement industries, announces 2020 membership with the International Probiotics Association (“IPA”). ... pertaining to probiotics. We are thrilled to join our IPA member colleagues and ...
(Date:2/5/2020)... ... February 04, 2020 , ... Crystal Diagnostics (CDx) ... a second patent related to proprietary liquid crystal technology for rapid and accurate ... the USPTO issued on December 3, 2019. Together, these patents protect the company’s ...
(Date:1/30/2020)... , ... January 30, 2020 , ... Accelera Canada ... eye on the Canadian market, is pleased to announce that the company has opened ... since the company launched in 2017. , “We are so thrilled to now ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... , ... January 27, 2020 , ... ... it has secured financing from strategic investors led by Halma plc , ... existing investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant ... surgery industry at two recent North American investor forums specializing in medical advancements. ... Medical Technologies & Diagnostics Forum on November 21, 2019 in New York City, ...
(Date:1/22/2020)... ... 21, 2020 , ... QCDx , a private biotech company that has ... today announced the sale of the proprietary RareScope™ instrument to the Carole and Ray ... clinical cancer research. , “The RareScope can detect and isolate intact and live Circulating ...
(Date:1/8/2020)... ... 2020 , ... Anomet Products has introduced new ... in harsh environments inside or outside of the human body. , ... to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from ...
Breaking Biology Technology:
Cached News: